Albion Financial Group UT Has $162,000 Stock Holdings in UnitedHealth Group Incorporated $UNH

Albion Financial Group UT trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 98.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 519 shares of the healthcare conglomerate’s stock after selling 34,034 shares during the quarter. Albion Financial Group UT’s holdings in UnitedHealth Group were worth $162,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the company. Citizens National Bank Trust Department raised its stake in shares of UnitedHealth Group by 1.0% during the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock worth $9,368,000 after purchasing an additional 170 shares in the last quarter. Fort Washington Investment Advisors Inc. OH lifted its stake in UnitedHealth Group by 0.3% in the first quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock valued at $277,641,000 after acquiring an additional 1,465 shares during the last quarter. Caitlin John LLC raised its holdings in shares of UnitedHealth Group by 14.8% during the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock valued at $451,000 after purchasing an additional 111 shares in the last quarter. Triumph Capital Management bought a new position in UnitedHealth Group during the second quarter valued at about $1,324,000. Finally, Wealth Effects LLC increased its holdings in shares of UnitedHealth Group by 14.4% during the 2nd quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock valued at $1,463,000 after acquiring an additional 591 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Down 0.4%

Shares of UNH stock opened at $344.15 on Monday. The stock has a market cap of $311.69 billion, a P/E ratio of 14.91, a price-to-earnings-growth ratio of 2.24 and a beta of 0.44. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The stock has a fifty day moving average price of $301.20 and a 200 day moving average price of $358.73. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. UnitedHealth Group’s revenue was up 12.9% on a year-over-year basis. During the same quarter last year, the firm posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.6%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

Analysts Set New Price Targets

A number of research firms have recently commented on UNH. Sanford C. Bernstein lifted their price target on shares of UnitedHealth Group from $337.00 to $379.00 and gave the company an “outperform” rating in a research report on Friday, September 5th. Barclays boosted their target price on shares of UnitedHealth Group from $337.00 to $352.00 and gave the stock an “overweight” rating in a research report on Thursday, September 4th. Oppenheimer dropped their price objective on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 30th. JPMorgan Chase & Co. lowered their target price on UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating on the stock in a report on Wednesday, August 6th. Finally, Baird R W cut UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 31st. Sixteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $358.95.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.